C39 BIOMARKERS AND PROGNOSTIC FACTORS IN ILD: A Comparative Analysis Of Rates Of Diagnosis, Treatment Initiation, And Treatment Persistence In Idiopathic Pulmonary Fibrosis (ipf) Versus Non-Small-Cell Lung Cancer (nsclc)

C39 BIOMARKERS AND PROGNOSTIC FACTORS IN ILD: A Comparative Analysis Of Rates Of Diagnosis, Treatment Initiation, And Treatment Persistence In Idiopathic Pulmonary Fibrosis (ipf) Versus Non-Small-Cell Lung Cancer (nsclc)

Methods: Using epidemiological data gathered through a combination of literature searches (prevalence rates) and proprietary primary research (IPF diagnosis, treatment initiation and persistence rates), the proportion of patients moving between each stage of the patient journey (presentation of symp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser: Denton, J, Phillips, C, Del Carlo, A, Mavaddat, A, Carter, E, Dejonckheere, F, Munk, V C, Molnar, E
Format: Artikel
Sprache:eng
Schlagworte:
Disease
Lung cancer
Medical diagnosis
Medical prognosis
Patients
Pulmonary fibrosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods: Using epidemiological data gathered through a combination of literature searches (prevalence rates) and proprietary primary research (IPF diagnosis, treatment initiation and persistence rates), the proportion of patients moving between each stage of the patient journey (presentation of symptoms, diagnosis, treatment initiation, and treatment persistence) for both IPF and NSCLC was simulated. Factors with the highest impact on treatment persistence in IPF included suboptimal management of adverse events and lack of patient education on the benefits of treatment.
ISSN:1073-449X
1535-4970